Prevention of experimental liver metastases by arabinogalactan.
D000818:Animals; D005685:Galactans / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000556:secondary*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000556:secondary*; D051379:Mice; D008807:Mice, Inbred BALB C; D009439:Neuraminidase / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000473:pathology*
D005685:Galactans; D009439:Neuraminidase; C005653:arabinogalactan